Quantum Biopharma Ltd (QNTM)

$3.45 +0.22 (6.81%)
Market Cap 22.08M
Revenue (ttm) 0.00
Net Income (ttm) -26.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 181,900
Avg Vol 177,726
Day's Range N/A - N/A
Shares Out 6.40M
Stochastic %K 76%
Beta 0.45
Analysts Sell
Price Target $35.50

Company Profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a patented new chemical enti...

Industry: Biotechnology
Sector: Healthcare
Phone: 833 571 1811
Address:
1 Adelaide Street East, Suite 801, Toronto, Canada
DarkKingTrade
DarkKingTrade Aug. 10 at 1:05 PM
$QNTM 10$
0 · Reply
ec017
ec017 Aug. 10 at 12:39 PM
$QNTM pump & dump on 10,000 shares? That’s called no volume Lmao Also the news today is the news that this stock was waiting on back in May when it was trading at 10 bucks before it sold off because they didn’t get this news. Less emotions, more facts bud.
1 · Reply
FickleFin
FickleFin Aug. 10 at 12:27 PM
$QNTM clearly a pump and dump whenever they get a chance. 4am sell off. Red candles throwing the middle finger. 😅😅😅
0 · Reply
Tsion
Tsion Aug. 10 at 12:27 PM
$QNTM break 3.50 and fly
0 · Reply
FickleFin
FickleFin Aug. 10 at 12:15 PM
$QNTM they sold on you. News today was just an approval to start next step. Bunk press release 🥴🥴🥴.
0 · Reply
Tsion
Tsion Aug. 10 at 11:29 AM
$QNTM good fda news
0 · Reply
DarkKingTrade
DarkKingTrade Aug. 10 at 11:27 AM
$QNTM It received Phase 2 for a unique drug. And there is $10 million in cash in the safe.💥💥💥🤌🏻🤌🏻💯
0 · Reply
ec017
ec017 Aug. 10 at 11:17 AM
$QNTM wasn’t this 10 bucks in May on the suspected news that came out today? Then they had a hiccup so it sold off etc But if this stock was trading around 10 bucks there’s no reason we haven’t moved yet
0 · Reply
Tsion
Tsion Aug. 10 at 11:05 AM
$QNTM in 3.20
0 · Reply
DaGreenLantern
DaGreenLantern Aug. 10 at 11:02 AM
$QNTM wen 5$ ?
0 · Reply
Latest News on QNTM
Quantum BioPharma Announces Closing of Debt Settlement

Thu, 30 Jul 2026 00:18:00 -0400 - 11 days ago

Quantum BioPharma Announces Closing of Debt Settlement

Quantum BioPharma Announces Intention to Settle Debt

Mon, 20 Jul 2026 19:00:00 -0400 - 20 days ago

Quantum BioPharma Announces Intention to Settle Debt

Quantum BioPharma Provides Corporate Update

Tue, 07 Jul 2026 19:00:00 -0400 - 4 weeks ago

Quantum BioPharma Provides Corporate Update

NetworkNewsAudio Announces Audio Press Release (APR) the Advancement of First-in-Class Treatment for Multiple Sclerosis

Fri, 26 Jun 2026 08:30:00 -0400 - 6 weeks ago

NetworkNewsAudio Announces Audio Press Release (APR) the Advancement of First-in-Class Treatment for Multiple Sclerosis

Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy

Thu, 25 Jun 2026 08:30:00 -0400 - 6 weeks ago

Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy

Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach

Tue, 23 Jun 2026 08:30:00 -0400 - 6 weeks ago

Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.

Tue, 02 Jun 2026 08:00:00 -0400 - 2 months ago

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.

Quantum BioPharma Engages Stocks.news For Investor Relations, Marketing Services And Lead Generation Campaigns

Tue, 02 Jun 2026 07:40:00 -0400 - 2 months ago

Quantum BioPharma Engages Stocks.news For Investor Relations, Marketing Services And Lead Generation Campaigns

Quantum BioPharma Provides Corporate Update

Mon, 01 Jun 2026 19:30:00 -0400 - 2 months ago

Quantum BioPharma Provides Corporate Update

Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital

Mon, 18 May 2026 03:00:00 -0400 - 3 months ago

Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital

Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026

Thu, 07 May 2026 07:00:00 -0400 - 3 months ago

Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026

Quantum BioPharma Provides Corporate Update

Mon, 27 Apr 2026 19:45:00 -0400 - 3 months ago

Quantum BioPharma Provides Corporate Update

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant

Wed, 22 Apr 2026 09:16:00 -0400 - 3 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant

Quantum BioPharma submits Lucid-21-302 new drug application to the FDA

2026-04-01T12:25:14.000Z - 4 months ago

Quantum BioPharma submits Lucid-21-302 new drug application to the FDA

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

Wed, 01 Apr 2026 08:02:00 -0400 - 4 months ago

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

2026-03-30T12:47:57.000Z - 4 months ago

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

2026-03-30T12:28:19.000Z - 4 months ago

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis

Mon, 30 Mar 2026 07:50:00 -0400 - 4 months ago

Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis

Quantum Biopharma Provides Corporate Update

Fri, 27 Mar 2026 19:30:00 -0400 - 4 months ago

Quantum Biopharma Provides Corporate Update

Quantum Biopharma's 2025 Audited Year End Financial Results Maintain ‘No Going Concern' Status

Fri, 27 Mar 2026 08:10:00 -0400 - 4 months ago

Quantum Biopharma's 2025 Audited Year End Financial Results Maintain ‘No Going Concern' Status

Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

Mon, 23 Mar 2026 08:24:00 -0400 - 5 months ago

Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering

Fri, 20 Mar 2026 19:35:00 -0400 - 5 months ago

Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering

Quantum BioPharma Provides Corporate Update

Wed, 11 Mar 2026 19:55:00 -0400 - 5 months ago

Quantum BioPharma Provides Corporate Update

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

Thu, 19 Feb 2026 19:29:00 -0500 - 6 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Thu, 19 Feb 2026 12:00:00 -0500 - 6 months ago

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma, Ltd. Investors

Tue, 17 Feb 2026 13:55:00 -0500 - 6 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma, Ltd. Investors

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Tue, 17 Feb 2026 12:59:00 -0500 - 6 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Portnoy Law Firm Announces Class Action on Behalf of Quantum Corporation Investors

Tue, 17 Feb 2026 09:41:00 -0500 - 6 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Corporation Investors

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

Thu, 12 Feb 2026 16:02:00 -0500 - 6 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Tue, 03 Feb 2026 13:12:00 -0500 - 6 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors

Mon, 02 Feb 2026 10:46:00 -0500 - 6 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Tue, 27 Jan 2026 13:42:00 -0500 - 6 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

Dec 23, 2025, 8:00 AM EST - 8 months ago

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

Mon, 22 Dec 2025 09:00:00 -0500 - 8 months ago

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update

Dec 10, 2025, 8:00 PM EST - 8 months ago

Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update

Quantum BioPharma announces airing of news segment on manipulation lawsuit

2025-12-01T12:15:18.000Z - 9 months ago

Quantum BioPharma announces airing of news segment on manipulation lawsuit

Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC

Nov 27, 2025, 4:00 PM EST - 9 months ago

Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC

Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

Nov 26, 2025, 9:30 AM EST - 9 months ago

Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

Quantum BioPharma reports Q3 EPS ($1.25) vs. (4.37) last year

2025-11-07T12:12:42.000Z - 9 months ago

Quantum BioPharma reports Q3 EPS ($1.25) vs. (4.37) last year

Quantum BioPharma sees cash runway beyond March 2027

2025-11-07T12:11:35.000Z - 9 months ago

Quantum BioPharma sees cash runway beyond March 2027

Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

Nov 7, 2025, 7:00 AM EST - 9 months ago

Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

Quantum BioPharma Ltd. Provides Corporate Update

Oct 31, 2025, 7:51 PM EDT - 10 months ago

Quantum BioPharma Ltd. Provides Corporate Update

Quantum BioPharma Ltd. Announces Corporate Updates

Oct 29, 2025, 9:00 PM EDT - 10 months ago

Quantum BioPharma Ltd. Announces Corporate Updates

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication

Oct 23, 2025, 8:15 AM EDT - 10 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication

Quantum BioPharma announces expiration of warrants held by hedge funds

2025-10-20T12:40:40.000Z - 10 months ago

Quantum BioPharma announces expiration of warrants held by hedge funds

Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

Oct 20, 2025, 8:30 AM EDT - 10 months ago

Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group

Oct 14, 2025, 8:15 AM EDT - 10 months ago

Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group

Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM

Oct 9, 2025, 6:00 PM EDT - 10 months ago

Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM

QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm

Oct 9, 2025, 5:40 PM EDT - 10 months ago

QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm

Quantum BioPharma offers cash reward up to $7M for market manipulation proof

2025-10-08T12:15:28.000Z - 10 months ago

Quantum BioPharma offers cash reward up to $7M for market manipulation proof

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Oct 8, 2025, 8:00 AM EDT - 10 months ago

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

Oct 7, 2025, 11:00 AM EDT - 10 months ago

Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

Quantum BioPharma announces record date for special dividend distribution

2025-10-03T11:10:25.000Z - 11 months ago

Quantum BioPharma announces record date for special dividend distribution

Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

Oct 3, 2025, 7:00 AM EDT - 11 months ago

Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

Quantum BioPharma receives final reports for two studies of Lucid-21-302

2025-10-02T12:00:38.000Z - 11 months ago

Quantum BioPharma receives final reports for two studies of Lucid-21-302

Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

Oct 2, 2025, 7:57 AM EDT - 11 months ago

Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

Oct 1, 2025, 7:50 AM EDT - 11 months ago

Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders

Sep 29, 2025, 7:40 AM EDT - 11 months ago

Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders

Quantum BioPharma Announces Corporate Updates

Sep 26, 2025, 8:00 PM EDT - 11 months ago

Quantum BioPharma Announces Corporate Updates

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025

Sep 24, 2025, 8:30 AM EDT - 11 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025

Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance

Sep 18, 2025, 8:10 AM EDT - 11 months ago

Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance

Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT

Sep 12, 2025, 7:50 AM EDT - 11 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

Sep 10, 2025, 7:00 AM EDT - 11 months ago

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

Quantum BioPharma Announces Update to Previously Announced Private Placement

Aug 11, 2025, 6:32 PM EDT - 1 year ago

Quantum BioPharma Announces Update to Previously Announced Private Placement

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

Aug 11, 2025, 7:40 AM EDT - 1 year ago

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt

Aug 7, 2025, 7:00 AM EDT - 1 year ago

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Aug 5, 2025, 7:34 AM EDT - 1 year ago

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

Aug 4, 2025, 7:33 AM EDT - 1 year ago

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Jul 31, 2025, 7:24 AM EDT - 1 year ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

Jul 22, 2025, 7:00 AM EDT - 1 year ago

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

GME

Quantum BioPharma Announces Private Placement

Jun 27, 2025, 4:30 PM EDT - 1 year ago

Quantum BioPharma Announces Private Placement

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Jun 26, 2025, 7:30 AM EDT - 1 year ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

DarkKingTrade
DarkKingTrade Aug. 10 at 1:05 PM
$QNTM 10$
0 · Reply
ec017
ec017 Aug. 10 at 12:39 PM
$QNTM pump & dump on 10,000 shares? That’s called no volume Lmao Also the news today is the news that this stock was waiting on back in May when it was trading at 10 bucks before it sold off because they didn’t get this news. Less emotions, more facts bud.
1 · Reply
FickleFin
FickleFin Aug. 10 at 12:27 PM
$QNTM clearly a pump and dump whenever they get a chance. 4am sell off. Red candles throwing the middle finger. 😅😅😅
0 · Reply
Tsion
Tsion Aug. 10 at 12:27 PM
$QNTM break 3.50 and fly
0 · Reply
FickleFin
FickleFin Aug. 10 at 12:15 PM
$QNTM they sold on you. News today was just an approval to start next step. Bunk press release 🥴🥴🥴.
0 · Reply
Tsion
Tsion Aug. 10 at 11:29 AM
$QNTM good fda news
0 · Reply
DarkKingTrade
DarkKingTrade Aug. 10 at 11:27 AM
$QNTM It received Phase 2 for a unique drug. And there is $10 million in cash in the safe.💥💥💥🤌🏻🤌🏻💯
0 · Reply
ec017
ec017 Aug. 10 at 11:17 AM
$QNTM wasn’t this 10 bucks in May on the suspected news that came out today? Then they had a hiccup so it sold off etc But if this stock was trading around 10 bucks there’s no reason we haven’t moved yet
0 · Reply
Tsion
Tsion Aug. 10 at 11:05 AM
$QNTM in 3.20
0 · Reply
DaGreenLantern
DaGreenLantern Aug. 10 at 11:02 AM
$QNTM wen 5$ ?
0 · Reply
DaGreenLantern
DaGreenLantern Aug. 10 at 10:50 AM
$QNTM i think some shorts are unloading ammo early. This should reverse on good news.
0 · Reply
DarkKingTrade
DarkKingTrade Aug. 10 at 10:42 AM
$QNTM Phase 2 approval received. Big news! Target $10.
0 · Reply
DaGreenLantern
DaGreenLantern Aug. 10 at 10:41 AM
$QNTM why did it take a massive dip from 4's ?
0 · Reply
DaGreenLantern
DaGreenLantern Aug. 10 at 10:40 AM
$QNTM O.O
0 · Reply
Dexterous9
Dexterous9 Aug. 9 at 9:10 PM
$QNTM $1.4B cash, equivalents & investments at Q1 end💵..
1 · Reply
Wearewhowethought
Wearewhowethought Aug. 9 at 7:30 PM
$MMTLP $QNTM $MMTLP and others all gonna team up and make 4 billion
0 · Reply
Vapor83
Vapor83 Aug. 8 at 3:51 AM
$QNTM $9 by 9/1
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 7 at 6:34 PM
MissionIRNewsBreaks – $QNTM $QNTM.CN Advances Two-Pronged Approach to Neurological Health https://ibn.fm/Cn4nf
0 · Reply
Flippinn_Stockz
Flippinn_Stockz Aug. 7 at 5:26 PM
$NRXP $OABI $QNTM $VIVS $VSA VIVS moviiinggg .355 right now
0 · Reply
Flippinn_Stockz
Flippinn_Stockz Aug. 7 at 4:49 PM
$NRXP $OABI $QNTM $VIVS $VSA VIVS?🐳🍉🤯 Red to green? If it breaks .33 Its over for the shorts 100 percent
0 · Reply
Flippinn_Stockz
Flippinn_Stockz Aug. 7 at 4:44 PM
$NEXR $QNME $QNRX $QNTM $VIVS VIVS ctb rate is insaneeee🤯💣🐳
0 · Reply
Flippinn_Stockz
Flippinn_Stockz Aug. 7 at 4:41 PM
$NEXR $QNME $QNRX $QNTM $VIVS VIVS also can run….
0 · Reply